Receptor binding ligands, their use in the detection of cells with biological interest
US-9791435-B2 · Oct 17, 2017 · US
US9921214B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9921214-B2 |
| Application number | US-201313969044-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 16, 2013 |
| Priority date | Aug 21, 2012 |
| Publication date | Mar 20, 2018 |
| Grant date | Mar 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention is based on a method for performing a biochemical analysis, especially in outer space, wherein at least one analyte in a sample is determined qualitatively and/or quantitatively by means of selective binding of an analyte-specific pair composed of a binding substance and a detection substance to the analyte and by labeling by a labeling substance, and wherein the sample, the binding substance, the detection substance and the labeling substance are mixed in a reaction vessel in one method step. It is proposed that the mixing be brought about by means of mixing bodies.
Opening claim text (preview).
The invention claimed is: 1. A method for determining at least one analyte in a sample in outer space under conditions of reduced gravity, comprising: a) providing, in outer space, a device that comprises a reaction vessel and a magnet unit, wherein the reaction vessel comprises a detection region and an undetachably fixed capture antibody that binds to the at least one analyte, the undetachably fixed capture antibody located at a spatially predefined position of the reaction vessel within the detection region; b) mixing together the sample, a detection antibody that binds the at least one analyte, and magnetic inert bodies in the reaction vessel to form a complex composed of analyte, fixed capture antibody, and detection antibody; wherein the detection antibody carries bound to itself an enzyme capable of catalyzing a reaction that generates a detectable signal, wherein the magnetic inert bodies consist of magnetic or magnetizable particles that do not substantially bind to the at least one analyte in the sample, to the fixed capture antibody, or to the detection antibody, wherein the mixing is performed by motion of the magnetic inert bodies caused by application of an alternating magnetic field by the magnet unit, c) using the magnet unit to position the magnetic inert bodies outside the detection region; and d) determining the presence of the complex in the reaction vessel by performing optical techniques to measure the detectable signal to determine the at least one analyte in the sample. 2. The method of claim 1 , wherein in step c), the magnetic inert bodies are positioned in a corner of the reaction vessel outside of the detection region.
Analysers adapted for operation in microgravity, i.e. spaceflight · CPC title
with separation of immune complex from unbound antigen or antibody · CPC title
Magnetic particles · CPC title
Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.